April 7, 2014

Low-Dose Aspirin for Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force

Structured PICO

Does daily low-dose aspirin prevent morbidity and mortality from preeclampsia?

Population

Individuals at risk for morbidity and mortality from preeclampsia

Intervention

Daily low-dose aspirin beginning as early as the second trimester

Outcome

Morbidity and mortality from preeclampsiahard clinical

Daily low-dose aspirin starting in the second trimester prevents clinically important health outcomes related to preeclampsia without identified harms.

Abstract

Daily low-dose aspirin beginning as early as the second trimester prevented clinically important health outcomes. No harms were identified, but long-term evidence was limited.

KI fragen

Bookmark

Cite This Study

Henderson et al. (Mon,) studied this question.

synapsesocial.com/papers/69d9b7f60d540cafc58373c0 https://doi.org/https://doi.org/10.7326/m13-2844

KI fragen

Bookmark